scPharmaceuticals Inc

NASDAQ:SCPH  
4.79
-0.11 (-2.24%)
Earnings Announcements

scPharmaceuticals Inc Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/22/2022 11:41 GMT
scPharmaceuticals Inc (SCPH) - Scpharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Scpharmaceuticals Inc - Ended Q4 With Cash, Cash Equivalents, Restricted Cash and Investments of $75.5 Million.
Scpharmaceuticals Inc - Qtrly Loss per Share $0.27.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.